Literature DB >> 20378901

Previous history of gonococcal infection as a risk factor in patients presenting with gonorrhoea.

T Fowler1, M Caley, R Johal, R Brown, J D C Ross.   

Abstract

Recidivism is common in patients infected with gonorrhoea. Identifying the factors most closely associated with recurrent gonococcal infection can help to target health promotion and disease prevention interventions. A case-control study design was used to quantify the importance of past infection as a risk marker for gonorrhoea while controlling for other demographic and behavioural factors. Data were available for 134 cases of gonorrhoea and 150 controls. A history of gonorrhoea (odds ratio [OR] 4.36 [95% CI 1.78-10.71]) was the strongest predictor of current infection. The number of partners in the last month (OR 2.19 [95% CI 1.20-4.02]) was also significantly associated with a diagnosis of gonorrhoea. Patients presenting with gonorrhoea are a specific high-risk group who require additional interventions and should be prioritized for evidence-based, enhanced and interactive counselling.

Entities:  

Mesh:

Year:  2010        PMID: 20378901     DOI: 10.1258/ijsa.2009.009235

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  3 in total

1.  Global epidemiology of Neisseria gonorrhoeae in infertile populations: protocol for a systematic review.

Authors:  Hiam Chemaitelly; Manale Harfouche; Karel Blondeel; Thabo Christopher Matsaseng; James Kiarie; Igor Toskin; Laith J Abu-Raddad
Journal:  BMJ Open       Date:  2019-05-22       Impact factor: 2.692

2.  Global epidemiology of Neisseria gonorrhoeae in infertile populations: systematic review, meta-analysis and metaregression.

Authors:  Hiam Chemaitelly; Alzahraa Majed; Farah Abu-Hijleh; Karel Blondeel; Thabo Christopher Matsaseng; James Kiarie; Igor Toskin; Laith J Abu-Raddad
Journal:  Sex Transm Infect       Date:  2020-05-18       Impact factor: 3.519

Review 3.  Is gonococcal disease preventable? The importance of understanding immunity and pathogenesis in vaccine development.

Authors:  Jennifer L Edwards; Michael P Jennings; Michael A Apicella; Kate L Seib
Journal:  Crit Rev Microbiol       Date:  2016-01-23       Impact factor: 7.624

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.